References
- Spiller HA. Management of antidiabetic medications in overdose. Drug Saf 1998; 19(5)411–24
- Carr R, Zed PJ. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Ann Pharmacother 2002; 36(11)1727–32
- Sketris I, Wheeler D, York S. Hypoglycemic coma induced by inadvertent administration of glyburide. Drug Intell Clin Pharm 1984; 18(2)142–3
- Earle KE, Rushakoff RJ, Goldfine ID. Inadvertent sulfonylurea overdosage and hypoglycemia in an elderly woman: failure of serum hypoglycemia screening. Diabetes Technol Ther 2003; 5(3)449–51
- http://www.drugtopics.com/drugtopics/issue/issueDetail.jsp?id=5870
- Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC, Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2004; 22(5)335–404
- Szlatenyi CS, Capes KF, Wang RY. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Ann Emerg Med 1998; 31(6)773–6
- 8. Product Information: Micronase(R) oral tablet, glyburide oral tablet, USP. Pharmacia & Upjohn Company, Kalamazoo, MI, 2002.
- DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131(4)281–303
- van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50(6)735–41
- Melander A, Donnelly R, Rydberg T. Is there a concentration-effect relationship for sulphonylureas?. Clin Pharmacokinet 1998; 34(3)181–8